Search research articles
Contact Us
Filters
Showing results (11-20 of 87) with videos related to
Page
of 9
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
June 12, 2013
Pharmacokinetic considerations for antithrombotic therapies in stroke
Stavros Apostolakis, Gregory Yh Lip, Eduard Shantsila
Circulation
|
September 11, 2013
Letter by Apostolakis et al regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts"
Stavros Apostolakis, Deirdre A Lane, Amitava Banerjee
Expert Review of Cardiovascular Therapy
|
June 2, 2012
How early is early enough to prevent stroke in atrial fibrillation?
Yutao Guo, Gregory Yh Lip, Stavros Apostolakis
Journal of Atrial Fibrillation
|
May 13, 2017
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants
Konstantina Mitrousi, Gregory Y H Lip, Stavros Apostolakis
Current Opinion in Pharmacology
|
January 9, 2013
Aspirin and aspirin resistance in coronary artery disease
Charalampos Kasmeridis, Stavros Apostolakis, Gregory Y H Lip
Journal of Cardiovascular Translational Research
|
December 5, 2012
The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure
Yutao Guo, Gregory Y H Lip, Stavros Apostolakis
Journal of the American College of Cardiology
|
December 1, 2012
Inflammation in atrial fibrillation
Yutao Guo, Gregory Y H Lip, Stavros Apostolakis
Circulation
|
September 26, 2012
Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation
Pilar Gallego, Stavros Apostolakis, Gregory Y H Lip
Pharmacoeconomics
|
October 7, 2009
New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?
Stavros Apostolakis, Eduard Shantsila, Gregory Y H Lip
The Malaysian Journal of Medical Sciences : MJMS
|
April 24, 2013
The unmet need of stroke prevention in atrial fibrillation in the far East and South East Asia
Yutao Guo, Gregory Y H Lip, Stavros Apostolakis
Page
of 9
Search research articles
Search
Showing results (11-20 of 87) with videos related to
Sort By:
Page
of 9
Expert Opinion on Drug Metabolism & Toxicology
|
June 12, 2013
Pharmacokinetic considerations for antithrombotic therapies in stroke
Stavros Apostolakis, Gregory Yh Lip, Eduard Shantsila
Circulation
|
September 11, 2013
Letter by Apostolakis et al regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts"
Stavros Apostolakis, Deirdre A Lane, Amitava Banerjee
Expert Review of Cardiovascular Therapy
|
June 2, 2012
How early is early enough to prevent stroke in atrial fibrillation?
Yutao Guo, Gregory Yh Lip, Stavros Apostolakis
Journal of Atrial Fibrillation
|
May 13, 2017
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants
Konstantina Mitrousi, Gregory Y H Lip, Stavros Apostolakis
Current Opinion in Pharmacology
|
January 9, 2013
Aspirin and aspirin resistance in coronary artery disease
Charalampos Kasmeridis, Stavros Apostolakis, Gregory Y H Lip
Journal of Cardiovascular Translational Research
|
December 5, 2012
The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure
Yutao Guo, Gregory Y H Lip, Stavros Apostolakis
Journal of the American College of Cardiology
|
December 1, 2012
Inflammation in atrial fibrillation
Yutao Guo, Gregory Y H Lip, Stavros Apostolakis
Circulation
|
September 26, 2012
Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation
Pilar Gallego, Stavros Apostolakis, Gregory Y H Lip
Pharmacoeconomics
|
October 7, 2009
New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?
Stavros Apostolakis, Eduard Shantsila, Gregory Y H Lip
The Malaysian Journal of Medical Sciences : MJMS
|
April 24, 2013
The unmet need of stroke prevention in atrial fibrillation in the far East and South East Asia
Yutao Guo, Gregory Y H Lip, Stavros Apostolakis
Page
of 9